Insight Pharmaceuticals Corporation

FDA Regulatory Profile

Insight Pharmaceuticals Corporation appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0151-2024, Class I) was initiated on November 22, 2023.

Summary

Total Recalls
1 (1 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0151-2024Class ITING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (128 g) cansNovember 22, 2023